Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics.
about
Potential role of herbal remedies in stem cell therapy: proliferation and differentiation of human mesenchymal stromal cellsIn silico regenerative medicine: how computational tools allow regulatory and financial challenges to be addressed in a volatile marketRegenerative medicine in urologyDesign, materials, and mechanobiology of biodegradable scaffolds for bone tissue engineeringOn the genealogy of tissue engineering and regenerative medicineExploitation of physical and chemical constraints for three-dimensional microtissue construction in microfluidics.Laser-assisted cell printing: principle, physical parameters versus cell fate and perspectives in tissue engineering.Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor.Combinatorial and high-throughput screening of biomaterials.Biomechanics and mechanobiology in functional tissue engineering.The maintenance of pluripotency following laser direct-write of mouse embryonic stem cells.Regenerative medicine: the emergence of an industryMicroRNAs: modulators of cell identity, and their applications in tissue engineeringTissue engineering and regenerative medicine: semantic considerations for an evolving paradigm.Cryopreservation of Human Stem Cells for Clinical Application: A ReviewThe effect of 3D hydrogel scaffold modulus on osteoblast differentiation and mineralization revealed by combinatorial screening.Generating intestinal tissue from stem cells: potential for research and therapy.Fabricating gradient hydrogel scaffolds for 3D cell culture.Tissue engineering and regenerative medicine: recent innovations and the transition to translation.Application of whole-organ tissue engineering in hepatology.Embryonic wound healing: a primer for engineering novel therapies for tissue repair.Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophyEngineering extracellular matrix through nanotechnology.Vascular organogenesis: dream or reality?Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)?Creative cross-organizational collaboration: coming to a project near you.Thermal inkjet printing in tissue engineering and regenerative medicineDesign and development of reactive injectable and settable polymeric biomaterials.Engineered liver for transplantation.Future role of MR elastography in tissue engineering and regenerative medicine.Hype and expectations in tissue engineering.Translating Regenerative Biomaterials Into Clinical Practice.Review and the state of the art: Sol-gel and melt quenched bioactive glasses for tissue engineering.Challenges and opportunities in the manufacture and expansion of cells for therapy.Implantable Sensors for Regenerative Medicine.Biomek Cell Workstation: A Variable System for Automated Cell Cultivation.Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.The e-incubator: a magnetic resonance imaging-compatible mini incubator.Autologous cell therapies: challenges in US FDA regulation.The need for a regen industry voice.
P2860
Q26741837-F1CA7AD6-BB8D-4555-AE58-98A00E489CF2Q26751188-0B34D51A-B7D9-4A53-BEA7-67558BB2AF62Q27006859-9747D637-5D60-47C8-9693-AF0053D303FAQ28083524-D1582079-8012-4083-92D6-D6DBB44354BCQ28650026-A3E50AA0-F514-47D4-8AA1-888B3D31FAC9Q30474710-7F61D0EB-7D26-42D3-91AB-5A1CE98B026EQ33556135-5CA3BCCB-230C-4C50-BE26-83BB7331A2D8Q33588339-5538B1CB-5B74-4306-B607-8D3B267DCC5CQ33691846-1C9C244F-4895-45D5-949F-98679482AF3AQ33733279-3D34F396-871D-4C6A-83B6-36CF451F9A9BQ33775142-38EE0762-3BB6-4777-9AE1-A99F784A2DE3Q34333327-0E9213C9-8932-4BF6-88F4-EF4331659E5AQ34676147-06404627-5EC5-4F00-BA9A-0850AE9EFEBBQ34913995-9C1BB922-4BB0-49EF-9918-9FFF0F51CC08Q34939259-BB508121-C579-4792-9DD6-0E50200C1399Q35075101-CE99737B-542E-43B1-A494-5C5A5E9CCA5BQ35609422-01C968F4-5AC5-475D-94BA-6C6487110C20Q36053008-2EAC526A-BA6E-4D04-BD47-D95901DA5959Q36587765-5ACC60B1-0F26-4FA0-B334-D57E576F9538Q37066120-66D85C5D-7879-46B6-8948-C52A6E48DB57Q37419850-DC2BB11D-56ED-4E03-89D3-40F9F9AAD594Q37560090-3496EFD7-56A7-4F9E-B99A-4996C5D48860Q37791271-831C6511-7677-49B2-82CD-1EDE1CB784B4Q37825414-3BE34533-04C7-4C7B-8169-434E68319B0AQ37887670-0A3FBD0C-C306-4681-936F-9C32F2E86DE6Q37974973-A62C7FC6-47C6-4D2C-BD4B-D840D593D816Q37995757-386032DA-AB35-48F8-A515-5834BFC667B8Q38105523-583D73C2-08E2-4755-B1CF-1B4BB3756685Q38116230-1584405B-2B69-4B6B-833D-6E5E4880AE59Q38129841-878B6404-1677-41F6-B6B0-E88860A759C0Q38172304-E3CEF160-509E-4CC3-BAC8-AEFC373DC805Q38522439-376FA435-4D90-4FC4-A4C9-F65DD3F8E7CBQ38523506-DE295F9A-FB25-4FC0-AC82-7B7B2B32A52FQ38646797-5D172637-502C-476C-94C9-F8557762986EQ38781585-A311E188-12B7-4709-AF50-04D7EAF23352Q38844863-6D1EBEA0-C15F-4530-9F22-B71DA0A17BABQ38894255-C7D7AB83-B286-476C-9365-378D890DDCFCQ42273602-E0A17E63-1829-4E64-8BF4-5BD4B90A2C3EQ42697460-0DC3DAE7-CF9E-4CB5-8D6E-696528BA5672Q47379490-D8DF13C0-D2EE-4857-9285-A55478F25944
P2860
Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Great expectations: private se ...... e, and stem cell therapeutics.
@en
Great expectations: private se ...... e, and stem cell therapeutics.
@nl
type
label
Great expectations: private se ...... e, and stem cell therapeutics.
@en
Great expectations: private se ...... e, and stem cell therapeutics.
@nl
prefLabel
Great expectations: private se ...... e, and stem cell therapeutics.
@en
Great expectations: private se ...... e, and stem cell therapeutics.
@nl
P356
P1476
Great expectations: private se ...... e, and stem cell therapeutics.
@en
P2093
Elizabeth Deweerd
Michael J Lysaght
P304
P356
10.1089/TEA.2007.0267
P50
P577
2008-02-01T00:00:00Z